In the preceding three months, 20 analysts have released ratings for Eli Lilly (NYSE:LLY), presenting a wide array of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 8 | 12 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 3 | 0 | 0 | 0 |
| 2M Ago | 5 | 5 | 0 | 0 | 0 |
| 3M Ago | 1 | 4 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $992.05, a high estimate of $1125.00, and a low estimate of $884.00. Witnessing a positive shift, the current average has risen by 7.74% from the previous average price target of $920.74.
Investigating Analyst Ratings: An Elaborate Study
In examining recent analyst actions...
Login or create a forever free account to read this news
Sign up/Log in
